» Articles » PMID: 31628324

Identification of Atrial Fibrillation Associated Genes and Functional Non-coding Variants

Abstract

Disease-associated genetic variants that lie in non-coding regions found by genome-wide association studies are thought to alter the functionality of transcription regulatory elements and target gene expression. To uncover causal genetic variants, variant regulatory elements and their target genes, here we cross-reference human transcriptomic, epigenomic and chromatin conformation datasets. Of 104 genetic variant regions associated with atrial fibrillation candidate target genes are prioritized. We optimize EMERGE enhancer prediction and use accessible chromatin profiles of human atrial cardiomyocytes to more accurately predict cardiac regulatory elements and identify hundreds of sub-threshold variants that co-localize with regulatory elements. Removal of mouse homologues of atrial fibrillation-associated regions in vivo uncovers a distal regulatory region involved in Gja1 (Cx43) expression. Our analyses provide a shortlist of genes likely affected by atrial fibrillation-associated variants and provide variant regulatory elements in each region that link genetic variation and target gene regulation, helping to focus future investigations.

Citing Articles

Meta-analysis of genome-wide associations and polygenic risk prediction for atrial fibrillation in more than 180,000 cases.

Roselli C, Surakka I, S Olesen M, Sveinbjornsson G, Marston N, Choi S Nat Genet. 2025; 57(3):539-547.

PMID: 40050429 DOI: 10.1038/s41588-024-02072-3.


Genetic and Molecular Underpinnings of Atrial Fibrillation.

Sweat M, Pu W NPJ Cardiovasc Health. 2025; 1.

PMID: 39867228 PMC: 11759492. DOI: 10.1038/s44325-024-00035-5.


Atrial fibrillation variant-to-gene prioritization through cross-ancestry eQTL and single-nucleus multiomic analyses.

Leblanc F, Jin X, Kang K, Lee C, Xu J, Xuan L iScience. 2024; 27(9):110660.

PMID: 39262787 PMC: 11388022. DOI: 10.1016/j.isci.2024.110660.


Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation.

Linna-Kuosmanen S, Vuori M, Kiviniemi T, Palmu J, Niiranen T Eur Heart J Suppl. 2024; 26(Suppl 4):iv33-iv40.

PMID: 39099578 PMC: 11292413. DOI: 10.1093/eurheartjsupp/suae072.


Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American....

Goette A, Corradi D, Dobrev D, Aguinaga L, Cabrera J, Chugh S Europace. 2024; 26(9).

PMID: 39077825 PMC: 11431804. DOI: 10.1093/europace/euae204.


References
1.
Parsons M, Brancaccio M, Sethi S, Maywood E, Satija R, Edwards J . The Regulatory Factor ZFHX3 Modifies Circadian Function in SCN via an AT Motif-Driven Axis. Cell. 2015; 162(3):607-21. PMC: 4537516. DOI: 10.1016/j.cell.2015.06.060. View

2.
Camelliti P, Green C, LeGrice I, Kohl P . Fibroblast network in rabbit sinoatrial node: structural and functional identification of homogeneous and heterogeneous cell coupling. Circ Res. 2004; 94(6):828-35. DOI: 10.1161/01.RES.0000122382.19400.14. View

3.
Wang S, Wen F, Wiley G, Kinter M, Gaffney P . An enhancer element harboring variants associated with systemic lupus erythematosus engages the TNFAIP3 promoter to influence A20 expression. PLoS Genet. 2013; 9(9):e1003750. PMC: 3764111. DOI: 10.1371/journal.pgen.1003750. View

4.
Deng W, Lee J, Wang H, Miller J, Reik A, Gregory P . Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell. 2012; 149(6):1233-44. PMC: 3372860. DOI: 10.1016/j.cell.2012.03.051. View

5.
Workman A . Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol. 2009; 381(3):235-49. PMC: 2855383. DOI: 10.1007/s00210-009-0474-0. View